Adverse Effects. Any agreement under which the consequences of a default or termination could have a material adverse effect on the business, financial condition, operations, results of operations or future prospects of the Company; and
Adverse Effects. The Awardee shall forfeit or otherwise be deprived of its charter, articles of organization, franchises, permits, easements, consents or licenses required to carry on any material portion of its business or the Awardee files for or an event occurs which can reasonably be expected to result in its dissolution or termination;
Adverse Effects. In the introduction of technological change the Corporation will seek ways and means of minimizing adverse effects on employees which might result from such change.
Adverse Effects. No Member should cause, through the use of any subsidy referred to in paragraphs 1 and 2 of Article 1, adverse effects to the interests of other Members, i.e.:
(a) injury to the domestic industry of another Member11;
(b) nullification or impairment of benefits accruing directly or indirectly to other Members under GATT 1994 in particular the benefits of concessions bound under Article II of GATT 199412;
(c) serious prejudice to the interests of another Member.13 This Article does not apply to subsidies maintained on agricultural products as provided in Article 13 of the Agreement on Agriculture.
Adverse Effects. Each Party shall promptly inform the other in writing of any material side effects or adverse effects, conditions or reactions encountered by or reported to them in connection with the Product(s) which could in any significant way render the Product(s) or any of the components thereof unsafe or unfit. The Parties shall follow a written mutually agreed upon procedure for communication of Adverse Events relating to the Product(s). These procedures will be agreed to by the Parties prior to the initiation of clinical trials in the Territory.
Adverse Effects. Licensor and Licensee agree to report to any regulatory body within the statutory term and to the other, within forty-eight (48) hours from receipt of information, any serious adverse effect that is reported to occur because of the use of products or processes associated with the Patent Rights.
Adverse Effects. There is no fact within the knowledge of the Company as of the Closing Date (other than publicly known facts relating to political or economic matters of general applicability that may adversely affect all comparable entities) that will have a material adverse effect on the Company's business, condition, assets, liabilities, operations, financial performance, net income or prospects or on the ability of the Company to comply with or perform any covenant or obligation under this Agreement; subject however to the risk factors and disclosures set forth in the SEC Filings, including but not limited to the risk factors and disclosures relating to the Pick Merger as set forth in the Merger Proxy Statement.
Adverse Effects. Since September 30, 2007, Tianyin has not experienced or suffered any Material Adverse Effect.
Adverse Effects. The Borrower shall forfeit or otherwise be deprived of its charter, articles of organization, franchises, permits, easements, consents or licenses required to carry on any material portion of its business or the Borrower files for or an event occurs which can reasonably be expected to result in its dissolution or termination;
Adverse Effects. 14.1 In the event one or more of the Study Subjects sustain any adverse effects related to the Study, the Principal Investigator shall inform the Sponsor and the Institution’s Helsinki Committee and/or the Institution's management and/or the authorized national health authorities. The Principal Investigator and the Institution are also entitled to immediately cease the performance of the Study and report their decision to the Sponsor subject to the terms stated above.
14.2 In the aforementioned event, the Sponsor undertakes to break the study medication’s code and immediately inform the Principal Investigator and/or the Institution the content of the medication received by each Study Subject. The Sponsor will also immediately take all measures at its disposal, to evaluate the risk to the other Study Subject and will instruct the Principal Investigator which measures to take in regard to that risk.
